Sightera Biosciences raises $3.3M pre seed

◆ Amount

$3.3M

◆ Announced

20 Jul 2026

◆ Company

◆ Source

◆ The Round

Sightera Biosciences raised $3.3M in pre seed funding, announced on 20 July 2026, led by Entourage Ventures, Anacura, Qbic Fund. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Sightera Biosciences

Patient-derived AI drug discovery platform based in Antwerp. Sightera Biosciences is based in Belgium and currently at pre seed stage, operating in healthtech, deeptech.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Sightera Biosciences's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market